SCHEMBL24468313

SCHEMBL24468313

C[C@H](c1ccc(-c2ccc(C(F)(F)F)cc2)nn1)N(C)C(=O)OC(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 1/20 0.36
TRPV3 Q8NET8 3/20 0.35
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
P2RY14 Q15391 1/20 0.35
MAOB P27338 1/20 0.34
CACNA1G O43497 1/20 0.34
CACNA1B Q00975 1/20 0.34
CACNA1C Q13936 1/20 0.34
GPR119 Q8TDV5 1/20 0.34
LMNA P02545 1/20 0.34
KMT2A Q03164 1/20 0.34
AAK1 Q2M2I8 2/20 0.34
SCN9A Q15858 3/20 0.33
BCHE P06276 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29685934 1.00 CASP1 (0.36) CASP1TRPV3ALDH1A1KDM4ENPC1
SCHEMBL30803836 0.79 SLC6A9 (0.41)
SCHEMBL29686000 0.75 LMNA (0.40) NPC1SMN1; SMN2LMNAKMT2AAAK1
SCHEMBL24468312 0.75 LMNA (0.40) NPC1SMN1; SMN2LMNAKMT2AAAK1
SCHEMBL1549826 0.73 PAX8 (0.46) ALDH1A1KDM4ENPC1MAPTHPGD
SCHEMBL2609362 0.73 MAOB (0.43) CASP1TRPV3MAOB
SCHEMBL29106458 0.72 CASP1 (0.45) CASP1TRPV3ALDH1A1L3MBTL1MAOB
SCHEMBL5937941 0.68 ALDH1A1 (0.39) TRPV3ALDH1A1KDM4ENPC1MAPT
SCHEMBL24468310 0.68 KIF11 (0.41) CASP1TRPV3MAOBLMNAADORA3
SCHEMBL29686526 0.68 KIF11 (0.41) CASP1TRPV3MAOBLMNAADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022115377-A1 TRICYCLIC CARBOXAMIDE DERIVATIVES AS PRMT5 INHIBITORS AMGEN INC. (US) 2022-06-02 WO disclosed